Galactosemias

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2026-06-04
EMA Application withdrawn: Nugalviq (govorestat) — Advanz Pharma Limited
The EMA has withdrawn the application for Nugalviq (govorestat) by Advanz Pharma Limited for galactosemias.